Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Income Statement
Earnings Waterfall
Y-mAbs Therapeutics Inc
Revenue
|
84.8m
USD
|
Cost of Revenue
|
-11.4m
USD
|
Gross Profit
|
73.5m
USD
|
Operating Expenses
|
-94.6m
USD
|
Operating Income
|
-21.2m
USD
|
Other Expenses
|
-237k
USD
|
Net Income
|
-21.4m
USD
|
Income Statement
Y-mAbs Therapeutics Inc
Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
21
N/A
|
26
+26%
|
37
+42%
|
46
+24%
|
35
-24%
|
40
+15%
|
40
0%
|
43
+9%
|
65
+50%
|
75
+15%
|
85
+13%
|
93
+9%
|
85
-9%
|
|
Gross Profit | ||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(2)
|
(4)
|
(5)
|
(7)
|
(7)
|
(8)
|
(11)
|
(11)
|
(11)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
5
N/A
|
16
+203%
|
24
+52%
|
33
+33%
|
36
+10%
|
35
-3%
|
37
+5%
|
58
+58%
|
67
+16%
|
74
+10%
|
82
+11%
|
73
-10%
|
|
Operating Income | ||||||||||||||||||||||||
Operating Expenses |
(31)
|
(38)
|
(43)
|
(52)
|
(60)
|
(73)
|
(83)
|
(94)
|
(115)
|
(124)
|
(141)
|
(147)
|
(140)
|
(145)
|
(148)
|
(151)
|
(167)
|
(166)
|
(153)
|
(137)
|
(116)
|
(105)
|
(95)
|
|
Selling, General & Administrative |
(7)
|
(9)
|
(9)
|
(11)
|
(14)
|
(16)
|
(20)
|
(24)
|
(30)
|
(37)
|
(45)
|
(49)
|
(52)
|
(54)
|
(55)
|
(56)
|
(66)
|
(65)
|
(61)
|
(59)
|
(47)
|
(43)
|
(44)
|
|
Research & Development |
(24)
|
(30)
|
(34)
|
(41)
|
(47)
|
(58)
|
(63)
|
(70)
|
(85)
|
(87)
|
(94)
|
(97)
|
(86)
|
(89)
|
(93)
|
(95)
|
(101)
|
(101)
|
(92)
|
(79)
|
(64)
|
(57)
|
(51)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(4)
|
(5)
|
(0)
|
|
Operating Income |
(31)
N/A
|
(38)
-25%
|
(43)
-12%
|
(52)
-20%
|
(60)
-16%
|
(73)
-21%
|
(83)
-13%
|
(94)
-13%
|
(115)
-23%
|
(124)
-7%
|
(120)
+3%
|
(121)
-1%
|
(104)
+15%
|
(100)
+4%
|
(115)
-16%
|
(115)
+0%
|
(132)
-15%
|
(129)
+2%
|
(95)
+27%
|
(70)
+26%
|
(42)
+40%
|
(24)
+44%
|
(21)
+10%
|
|
Pre-Tax Income | ||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
(4)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
62
|
62
|
62
|
62
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(0)
|
(0)
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
1
|
1
|
(0)
|
(1)
|
(1)
|
(4)
|
(2)
|
(3)
|
(4)
|
(1)
|
1
|
3
|
5
|
4
|
|
Pre-Tax Income |
(31)
N/A
|
(38)
-25%
|
(43)
-12%
|
(52)
-20%
|
(59)
-15%
|
(72)
-21%
|
(81)
-13%
|
(91)
-13%
|
(114)
-24%
|
(123)
-8%
|
(119)
+3%
|
(60)
+50%
|
(42)
+29%
|
(38)
+9%
|
(55)
-44%
|
(117)
-111%
|
(135)
-16%
|
(134)
+1%
|
(96)
+28%
|
(74)
+23%
|
(39)
+47%
|
(19)
+51%
|
(21)
-10%
|
|
Net Income | ||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
|
Income from Continuing Operations |
(31)
|
(38)
|
(43)
|
(52)
|
(59)
|
(72)
|
(81)
|
(91)
|
(114)
|
(123)
|
(119)
|
(60)
|
(42)
|
(38)
|
(55)
|
(117)
|
(135)
|
(134)
|
(96)
|
(74)
|
(39)
|
(19)
|
(21)
|
|
Net Income (Common) |
(31)
N/A
|
(38)
-25%
|
(43)
-12%
|
(52)
-20%
|
(59)
-15%
|
(72)
-21%
|
(81)
-13%
|
(91)
-13%
|
(114)
-24%
|
(123)
-8%
|
(119)
+3%
|
(60)
+50%
|
(42)
+29%
|
(38)
+9%
|
(55)
-44%
|
(117)
-111%
|
(135)
-16%
|
(134)
+1%
|
(96)
+28%
|
(74)
+23%
|
(39)
+47%
|
(19)
+51%
|
(21)
-11%
|
|
EPS (Diluted) |
-0.95
N/A
|
-1.18
-24%
|
-1.5
-27%
|
-1.51
-1%
|
-1.73
-15%
|
-2.09
-21%
|
-2.3
-10%
|
-2.29
+0%
|
-2.84
-24%
|
-3.04
-7%
|
-2.97
+2%
|
-1.34
+55%
|
-0.97
+28%
|
-0.87
+10%
|
-1.28
-47%
|
-2.67
-109%
|
-3.08
-15%
|
-3.05
+1%
|
-2.19
+28%
|
-1.69
+23%
|
-0.89
+47%
|
-0.44
+51%
|
-0.49
-11%
|